204 related articles for article (PubMed ID: 8355206)
1. Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
Etemadzadeh E
J Pharmacol Exp Ther; 1993 Aug; 266(2):749-55. PubMed ID: 8355206
[TBL] [Abstract][Full Text] [Related]
2. Cerebral dopamine and noradrenaline in mice withdrawn from repeated morphine treatment and development of tolerance to a test dose of morphine.
Etemadzadeh E
Gen Pharmacol; 1994 Jul; 25(4):623-9. PubMed ID: 7958720
[TBL] [Abstract][Full Text] [Related]
3. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
Attila LM; Ahtee L
Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
[TBL] [Abstract][Full Text] [Related]
4. Regional differences in cerebral noradrenaline turnover in mice withdrawn from repeated morphine treatment and tolerance to the effects of acute morphine.
Airio J; Attila M; Ahtee L
Pharmacol Toxicol; 1995 Sep; 77(3):196-203. PubMed ID: 8884883
[TBL] [Abstract][Full Text] [Related]
5. Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats.
Attila LM; Ahtee L
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):201-7. PubMed ID: 6541759
[TBL] [Abstract][Full Text] [Related]
6. Acceleration of cerebral noradrenaline turnover after morphine withdrawal and its retardation by acute morphine administration in rats.
Attila LM; Ahtee L
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):193-200. PubMed ID: 6541758
[TBL] [Abstract][Full Text] [Related]
7. Differences in the effects of morphine on the alpha-methyl-p-tyrosine-induced depletion of dopamine and noradrenaline in various areas of the mouse brain.
Martti L; Attila J; Etemadzadeh E; Ahtee L
Pharmacol Toxicol; 1987 Jul; 61(1):26-32. PubMed ID: 3628178
[TBL] [Abstract][Full Text] [Related]
8. Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state.
Ahtee L; Attila LM; Carlson KR; Haikala H
J Pharmacol Exp Ther; 1989 Apr; 249(1):303-10. PubMed ID: 2468763
[TBL] [Abstract][Full Text] [Related]
9. The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment.
Airio J; Ahtee L
Br J Pharmacol; 1999 Apr; 126(7):1609-19. PubMed ID: 10323593
[TBL] [Abstract][Full Text] [Related]
10. Effect of morphine on locomotor activity and striatal monoamine metabolism in nicotine-withdrawn mice.
Vihavainen T; Mijatovic J; Piepponen TP; Tuominen RK; Ahtee L
Behav Brain Res; 2006 Oct; 173(1):85-93. PubMed ID: 16846651
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal from repeated morphine sensitizes mice to the striatal dopamine release enhancing effect of acute morphine.
Airio J; Attila M; Leikola-Pelho T; Ahtee L
Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):548-54. PubMed ID: 7870194
[TBL] [Abstract][Full Text] [Related]
12. Modification of environmentally cued tolerance to ethanol in mice.
Melchior CL; Tabakoff B
J Pharmacol Exp Ther; 1981 Oct; 219(1):175-80. PubMed ID: 7288607
[TBL] [Abstract][Full Text] [Related]
13. [The brain catecholamine systems in the regulation of dominance].
Serova LI; Naumenko EV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
[TBL] [Abstract][Full Text] [Related]
14. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
Davis WM; Babbini M; Khalsa HJ
Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
[No Abstract] [Full Text] [Related]
15. Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
Mattila MJ; Alhava E; Mansner R
Arzneimittelforschung; 1968 Sep; 18(9):1163-6. PubMed ID: 5755932
[No Abstract] [Full Text] [Related]
16. Catecholamine utilization in distinct mouse brain nuclei during acute morphine treatment, morphine tolerance and withdrawal syndrome.
Kovács GL; Acsai L; Tihanyi A; Telegdy G
Eur J Pharmacol; 1983 Sep; 93(3-4):149-58. PubMed ID: 6685650
[TBL] [Abstract][Full Text] [Related]
17. [The action of low doses of bromocryptin in experimental morphine abstinence in rats].
Stanishevskaia AV; Khristoliubova NA; Vekshina NL; Varfolomeev SO; Anokhina IP
Farmakol Toksikol; 1991; 54(3):15-7. PubMed ID: 1655521
[TBL] [Abstract][Full Text] [Related]
18. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
J Pharmacol Exp Ther; 1998 May; 285(2):700-6. PubMed ID: 9580616
[TBL] [Abstract][Full Text] [Related]
19. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
20. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
